These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26743633)

  • 41. Utilization of Genetic Counseling after Direct-to-Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study.
    Koeller DR; Uhlmann WR; Carere DA; Green RC; Roberts JS;
    J Genet Couns; 2017 Dec; 26(6):1270-1279. PubMed ID: 28512697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pragmatic consideration of ethical issues relating to personal genomics.
    Hsu AR; Mountain JL; Wojcicki A; Avey L
    Am J Bioeth; 2009; 9(6-7):1-2. PubMed ID: 19998098
    [No Abstract]   [Full Text] [Related]  

  • 43. Direct-to-consumer genomics on the scales of autonomy.
    Vayena E
    J Med Ethics; 2015 Apr; 41(4):310-4. PubMed ID: 24797610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value.
    Mathews R; Hall W; Carter A
    Addiction; 2012 Dec; 107(12):2069-74. PubMed ID: 22510165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDA to regulate direct-to-consumer genetic tests.
    Brower V
    J Natl Cancer Inst; 2010 Nov; 102(21):1610-2, 1617. PubMed ID: 20966430
    [No Abstract]   [Full Text] [Related]  

  • 47. Direct-to-consumer genetic testing: good, bad or benign?
    Caulfield T; Ries NM; Ray PN; Shuman C; Wilson B
    Clin Genet; 2010 Feb; 77(2):101-5. PubMed ID: 19968666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The regulation of direct-to-consumer genetic tests.
    Kaye J
    Hum Mol Genet; 2008 Oct; 17(R2):R180-3. PubMed ID: 18852208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personal genomes: Misdirected precaution.
    Prainsack B; Reardon J; Hindmarsh R; Gottweis H; Naue U; Lunshof JE
    Nature; 2008 Nov; 456(7218):34-5. PubMed ID: 18987720
    [No Abstract]   [Full Text] [Related]  

  • 50. [A genetic ID for tomorrow?].
    Perbal L
    C R Biol; 2015; 338(8-9):547-53. PubMed ID: 26211982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Research 2.0: social networking and direct-to-consumer (DTC) genomics.
    Lee SS; Crawley L
    Am J Bioeth; 2009; 9(6-7):35-44. PubMed ID: 19998112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to 'know' your DNA.
    Samuel GN; Jordens CF; Kerridge I
    Intern Med J; 2010 Mar; 40(3):220-4. PubMed ID: 20446967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical application of genomic high-throughput data: Infrastructural, ethical, legal and psychosocial aspects.
    Umbach N; Beißbarth T; Bleckmann A; Duttge G; Flatau L; König A; Kuhn J; Perera-Bel J; Roschauer J; Schulze TG; Schweda M; Urban A; Zimmermann A; Sax U
    Eur Neuropsychopharmacol; 2020 Feb; 31():1-15. PubMed ID: 31866110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Customers or research participants? Guidance for research practices in commercialization of personal genomics.
    Tobin SL; Cho MK; Lee SS; Magnus DC; Allyse M; Ormond KE; Garrison NA
    Genet Med; 2012 Oct; 14(10):833-5. PubMed ID: 22699154
    [No Abstract]   [Full Text] [Related]  

  • 57. Naming and framing in genomic testing.
    Bunnik EM; Schermer MH; Janssens AC
    Trends Mol Med; 2014 Feb; 20(2):63-5. PubMed ID: 24485561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
    Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
    Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Welcome to the genomic era.
    Guttmacher AE; Collins FS
    N Engl J Med; 2003 Sep; 349(10):996-8. PubMed ID: 12954750
    [No Abstract]   [Full Text] [Related]  

  • 60. Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies.
    de Pauw A; Schwartz M; Colas C; Golmard L; Stoppa-Lyonnet D
    Eur J Cancer; 2020 Jun; 132():100-103. PubMed ID: 32335476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.